Compare · CI vs GRAL
CI vs GRAL
Side-by-side comparison of The Cigna Group (CI) and GRAIL Inc. (GRAL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and GRAL operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $78.96B, about 13.0x GRAL ($6.05B).
- GRAL has been more active in the news (10 items in the past 4 weeks vs 5 for CI).
- CI has more recent analyst coverage (25 ratings vs 14 for GRAL).
- Company
- The Cigna Group
- GRAIL Inc.
- Price
- -
- -
- Market cap
- $78.96B
- $6.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 10
- Recent ratings
- 25
- 14
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest CI
- SEC Form 8-K filed by The Cigna Group
- The Cigna Group's Third Quarter 2026 Earnings Release Details
- Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
- The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
- Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection
- Evercore ISI initiated coverage on The Cigna Group with a new price target
- The Cigna Group to Host Investor Day on September 30
- Officer Neville Everett sold $175,259 worth of shares (617 units at $284.05) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 5,053 units (SEC Form 4)
- Officer Evanko Brian C was granted 3,113 shares, increasing direct ownership by 8% to 41,030 units (SEC Form 4)
Latest GRAL
- SEC Form 4 filed by GRAIL Inc.
- SEC Form 4 filed by GRAIL Inc.
- SEC Form 4 filed by GRAIL Inc.
- SEC Form 4 filed by GRAIL Inc.
- SEC Form 4 filed by GRAIL Inc.
- SEC Form 4 filed by GRAIL Inc.
- GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
- FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test
- Chief Financial Officer Freidin Aaron sold $382,679 worth of shares (4,100 units at $93.34) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 248,983 units (SEC Form 4)
- Chief Executive Officer Ofman Joshua J. exercised 26,452 shares at a strike of $14.00 and sold $6,006,378 worth of shares (61,452 units at $97.74) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 362,271 units (SEC Form 4)